SMaRT technology enables gene expression repair in skin gene therapy

Journal of Investigative Dermatology

Volumn 128, Issue 3, 2008, Pages 499-500

  Hengge, Ulrich R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SMALL INTERFERING RNA;

DNA REPAIR; EPIDERMOLYSIS BULLOSA; GENE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENODERMATOSIS; HUMAN; LONGEVITY; MEDICAL TECHNOLOGY; NOTE; PLECTIN GENE; PRIORITY JOURNAL; RNA SEQUENCE; SPLICEOSOME; TRANS SPLICING;

EPIDERMOLYSIS BULLOSA SIMPLEX; GENE EXPRESSION; GENE THERAPY; HUMANS; RNA SPLICING;

EID: 39149138449     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701241     Document Type: Note

References (11)

1. Arin MJ, Roop DR (2004) Inducible mouse models for inherited skin diseases: implications for skin gene therapy. Cells Tissues Organs 177:160-8
2. Chao H, Mansfield SG, Bartel RC, Hiriyana S, Mitchell LG, Garcia-Blanco MA et al. (2003) Phenotype correction of hemophilia A in mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015-9
3. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-9
4. Hengge UR (2006) Gene therapy progress and prospects: the skin - easily accessible but still far away. Gene Ther 13:1555-63
5. Liu X, Jiang Q, Mansfield SG, Puttaraju M, Zhang Y, Zhou W et al. (2002) Partial correction of endogenous deltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 20:47-52
6. Mansfield SG, Clark RH, Puttaraju M, Kole J, Cohn JA, Mitchell LG et al. (2003) 5 exon replacement and repair by spliceosome-mediated RNA trans-splicing. RNA 9:1290-7
7. Ortiz-Urda S, Lin Q, Green CL, Keene DR, Marinkovich MP, Khavari PA (2003a) Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 111:251-5
8. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA (2003b) PhiC31 integrase mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther 14:923-8
9. Uitto J, Richard G (2004) Progress in epidermolysis bullosa: genetic classification and clinical implications. Am J Med Genet C 131:61-74
10. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S et al. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646-51
11. Wally V, Klausegger A, Koller U, Lochmüller H, Krause S, Wiche G et al. (2008) 5′ Trans-splicing repair of the PLEC1 gene. J Invest Dermatol 128:568-74